Expert perspectives live
from ASCO® 2025
At the 2025 ASCO® Annual Meeting, three of our experts sat down with OncoDaily to share their unique perspectives in oncology – from amplifying the patient voice to unlocking real-world impact through data and AI. Watch the videos below.
Matthew Hoelzle | Medical strategy, AI and real-world impact
Chief Medical Officer, Inizio Evoke
Matthew Hoelzle explores how AI and advanced analytics are reshaping medical strategy.
__________________________________________________________________________________________________
Matt Riordan | Accelerating cancer therapy adoption
CEO, Putnam
Matt Riordan shares his perspective on what’s needed to accelerate the adoption of cutting-edge cancer therapies.
__________________________________________________________________________________________________
Matt Wadyka | Elevating the patient voice in Medical Affairs
President, US Medical Affairs, Inizio Medical
In this conversation, Matt Wadyka discusses how Medical Affairs can better connect science with humanity.
__________________________________________________________________________________________________
Stay connected
For more insights and to explore how Inizio is advancing oncology innovation, follow us on LinkedIn. If you’re onsite this year, visit us at booth 10108.
Jump to a slide with the slide dots.
Inside ASCO® 2025: What oncologists really want from booth strategy
Congress engagement is being redefined - driven by oncologists’ learning preferences, AI integration, sustainability mandates, and smart booth design.
Read moreHow smart spaces and real-time strategy transformed ASCO® 2025
From LED walls to real-time in-booth optimization, ASCO® 2025 uncovered how we should engage and evolve the congress experience.
Read moreThe science is shifting in oncology: Are you ready to evolve with it?
It’s been a few weeks since ASCO® 2025, but one moment from the podium still echoes in my mind - the possibility of curing metastatic cancer.
Read more